E
EarliTec Dx
Providing accessible early identification and treatment of autism for children worldwide
About EarliTec Dx
EarliTec Diagnostics, Inc. specializes in developing advanced diagnostic tools for early identification and assessment of autism spectrum disorder (ASD). Utilizing clinically validated measures, the company creates technologies that help parents and healthcare providers understand where an individual child falls on the autism spectrum, enabling tailored treatment plans for optimal personal development. EarliTec's flagship product, EarliPoint, is FDA authorized and leverages social visual engagement research to improve autism diagnosis. The company primarily serves parents, clinicians, and healthcare providers, operating within the medical diagnostics market. EarliTec's business model revolves around selling its diagnostic tools and related services, generating revenue through product sales and potentially through service subscriptions or licensing agreements. The recent $21.5 million Series B financing round aims to accelerate the commercialization of EarliPoint and further product development.
Source: Dealroom company dataAt a glance
- Status
- Operational
- Founded
- 2019
- Headquarters
- Atlanta, United States
- Employees
- 37
- Open positions
- 1
- Dealroom signal
- 47.0/100
- Industry
- Health
- Sub-industry
- Medical Devices
- Sector
- Health Tech & Medtech, Autism, Neurology, Pediatrics, Health Diagnostics, Spinout, DT and LS, science-based
- Technology
- Deep Tech
- Client focus
- b2b
Knowledge graph
More headlines
Funding history
Company financing events and reported valuations.
| Deal type | Date | Amount | Valuation | Investors | Source |
|---|---|---|---|---|---|
| SERIES B✓Equity / VC | Apr 2024 | $22M | $86M | Venture Investors Health Fund · Nexus NeuroTech Ventures | ↗ |
| SERIES A✓Equity / VC | Feb 2022 | $20M | $78M | Georgia Research Alliance · Bernie Marcus | ↗ |
Growth signals
Latest recorded traffic for EarliTec Dx is 5K monthly website visits, up 100% over the last three months. EarliTec Dx's team grew 5.7% over the past year.
Similar companies
Company identity and context are open; selected comparison metrics preview what is available on the platform.
Investments and acquisitions
Recent portfolio relationships for companies that also act as investors or acquirers.
Investors
From Dealroom's funding and investor records, grouped by the round each investor first entered.
Series A4 investors entered at this stage
Georgia Research Alliance- BMBernie Marcus
Venture Investors Health Fund
Nexus NeuroTech Ventures
Other known investors4 additional known investors
Children's Healthcare Of Atlanta
Emory University School of Medicine
Yale University
GRA Venture Fund
Source: Dealroom Talent Intelligence.
Global footprint
team presence
Market sentiment
An AI-synthesised read of the highest-engagement posts about EarliTec Dx on X, ranked by likes and reposts, corporate channels excluded.
Reading the room on X — pulling top posts and synthesizing themes…
Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour
See EarliTec Dx’s full profile on Dealroom
Request a free trial to see the complete deal history, financials, people graph and growth signals.
Takes under a minute. Already use Dealroom? Log in.